AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT
Search National Drug Schedules Member Login

What's New

National Drug Scheduling Advisory Committee Meeting December 5, 2016

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for Monday, December 5, 2016. The primary purpose of the meeting is to consider the following matter:

• Request for Schedule II status for naloxone hydrochloride nasal spray, when indicated for emergency use for opioid overdose outside hospital settings

[> More]

Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules

Please note, this section will be updated periodically as the information becomes available.


  Reminder: Courses and PLAR exams available in both English and French

    NOTE: Selkirk College registration deadline for all English and French courses beginning in January 2017 is December 15, 2016


        Rappel :  Les cours et les examens ERA sont offerts en français et en anglais

  REMARQUE :  La date limite pour l’inscription aux cours (anglais et français) débutant en janvier 2017 au collège Selkirk est le 15 décembre 2016 

Registration deadlines for all institutions are available on the Course and PLAR Schedules page.

Registration for all courses is conducted directly with the educational institution offering the program.

Health Canada Advisory

Recall of SurThrival colostrum products due to undeclared milk allergens

Health Canada has requested that SurThrival voluntarily recall all lots of its colostrum products because they contain undeclared milk allergens, which may pose serious health risks to people who are allergic or hypersensitive to cow's milk. These authorized natural health products are marketed to strengthen the immune system, and can be found online and at various retailers across Canada.

Health Canada Advisory

Health Canada Advisory

Possible fire hazard with Formula kidney dialysis machines manufactured by Bellco

Health Canada is advising Canadians that Formula kidney dialysis machines manufactured by Bellco may pose a potential fire hazard. According to the company, the chance of a fire occurring is low and patients should continue using their machines for dialysis treatment until service technicians can take the appropriate safety precautions.

Health Canada Advisory

Health Product Risk Communication

Fluorouracil Injection, BP (5-fluorouracil) 5 g / 100 mL - Risk of Breach in Sterility and/or Exposure due to Vial Breakage or Leakage - Accord HealthCare Inc.

Accord Healthcare Canada Inc. and Health Canada have identified broken or leaking vials of Fluorouracil Injection, BP 5 g / 100 mL, a potent cytotoxic drug. Sterility of contents of the cracked or leaking vials could be compromised.

Health Canada Health Product Risk Communication

Foreign Product Alert

Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain undeclared drug ingredients. Prescription drugs should only be taken under the supervision of a health care practitioner.

These products are not authorized for sale in Canada and have not been found on the Canadian market, but they may have been brought into the country by travellers or purchased over the Internet.

27 unauthorized sex enhancement and weight loss products

Information Update

Health Canada updates Canadians on homeopathic teething products

Health Canada is following up with Canadians concerning the recent warning issued by the U.S. Food and Drug Administration (FDA) regarding possible safety issues involving homeopathic teething products in the United States.

Health Canada Information Update

Health Product Risk Communication

FASLODEX (fulvestrant) – Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels - AstraZeneca Canada Inc.

FASLODEX (fulvestrant) can interfere with antibody based estradiol measurement by immunoassay due to structural similarity of fulvestrant and estradiol. This can result in falsely elevated estradiol levels.

Health Canada Health Product Risk Communication

Information Update

Premature battery depletion with certain St. Jude Medical implantable defibrillators

Health Canada is advising Canadians that some batteries in implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy devices (CRT-D) manufactured by St. Jude Medical may deplete earlier than expected. Early battery depletion may occur suddenly, anywhere between hours and days, and without warning.

Health Canada Information Update



Gateway for international
Portail pour pharmaciens
formés à l’étranger




National Pharmacy Technician Bridging Education Program

Students and educational institutions can find more information about NAPRA's newest program.

NDSAC Drug Scheduling Applications

Find information about the NDSAC process and how to prepare scheduling applications.